Bolt Biotherapeutics盘中异动股价大涨5.04%报0.683美元_老虎社区_美港股上老虎

Bolt Biotherapeutics盘中异动股价大涨5.04%报0.683美元

市场透视10-25 22:09

北京时间2024年10月25日22时09分，Bolt Biotherapeutics（BOLT.us）股票出现异动，股价急速上涨5.04%。截至发稿，该股报0.683美元/股，成交量10.4956万股，换手率0.27%，振幅4.83%。最近的财报数据显示，该股实现营业收入1.28百万美元，净利润-21.20百万美元，每股收益-0.56美元，毛利818000.00美元，市盈率-0.39倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2478325939?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-25 22:09","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2478325939","market":"us","top_or_hot":-1,"title":"Bolt Biotherapeutics盘中异动 股价大涨5.04%报0.683美元","media":"市场透视","content":"<div>\n<p>北京时间2024年10月25日22时09分，Bolt Biotherapeutics（BOLT.us）股票出现异动，股价急速上涨5.04%。截至发稿，该股报0.683美元/股，成交量10.4956万股，换手率0.27%，振幅4.83%。最近的财报数据显示，该股实现营业收入1.28百万美元，净利润-21.20百万美元，每股收益-0.56美元，毛利818000.00美元，市盈率-0.39倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025220933971a2573&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bolt Biotherapeutics盘中异动 股价大涨5.04%报0.683美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBolt Biotherapeutics盘中异动 股价大涨5.04%报0.683美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-25 22:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025220933971a2573&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月25日22时09分，Bolt Biotherapeutics（BOLT.us）股票出现异动，股价急速上涨5.04%。截至发稿，该股报0.683美元/股，成交量10.4956万股，换手率0.27%，振幅4.83%。最近的财报数据显示，该股实现营业收入1.28百万美元，净利润-21.20百万美元，每股收益-0.56美元，毛利818000.00美元，市盈率-0.39倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025220933971a2573&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELAB","symbol_name":"Elevai Labs, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025220933971a2573&s=b","article_id":"2478325939","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025220933971a2573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2478325939","pubTimestamp":1729865372,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月25日22时09分，Bolt Biotherapeutics股票出现异动，股价急速上涨5.04%。截至发稿，该股报0.683美元/股，成交量10.4956万股，换手率0.27%，振幅4.83%。Bolt Biotherapeutics股票所在的生物技术行业中，整体涨幅为0.79%。Bolt Biotherapeutics公司简介：Bolt Biotherapeutics Inc是一家临床阶段的免疫肿瘤公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ELAB":"Elevai Labs, Inc.","BK4139":"生物科技","BK4183":"个人用品","BOLT":"Bolt Biotherapeutics, Inc."},"translate_title":"Bolt Biotherapeutics shares rose 5.04% to $0.683 after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BOLT":0.9,"ELAB":0.84},"content_text":"北京时间2024年10月25日22时09分，Bolt Biotherapeutics（BOLT.us）股票出现异动，股价急速上涨5.04%。截至发稿，该股报0.683美元/股，成交量10.4956万股，换手率0.27%，振幅4.83%。最近的财报数据显示，该股实现营业收入1.28百万美元，净利润-21.20百万美元，每股收益-0.56美元，毛利818000.00美元，市盈率-0.39倍。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Bolt Biotherapeutics股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Elevai Labs, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm (Holdings) Plc较为活跃，换手率分别为700.55%、624.56%、133.45%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)、Elevai Labs, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 (To Pur Com)，振幅分别为77.79%、68.33%、64.60%。Bolt Biotherapeutics公司简介：Bolt Biotherapeutics Inc是一家临床阶段的免疫肿瘤公司。该公司正在开发利用先天免疫系统和适应性免疫系统的力量的肿瘤靶向疗法。该公司的产品管线候选者是基于其对髓系生物学和癌症药物开发的深厚专业知识。该公司的专有Boltbody ISAC平台技术结合了肿瘤靶向抗体和免疫刺激连接剂-荷载。该公司的产品管线包括BDC-1001、BDC-3042和Next-Gen ISAC。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}